Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group
- 30 September 2004
- journal article
- clinical trial
- Published by Elsevier BV in Urology
- Vol. 64 (3), 479-484
- https://doi.org/10.1016/j.urology.2004.04.024
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Southwest Oncology Group Study of Paclitaxel and Carboplatin for Advanced Transitional-Cell Carcinoma: The Importance of Survival as a Clinical Trial End PointJournal of Clinical Oncology, 2000
- Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma.Journal of Clinical Oncology, 1998
- Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen.Journal of Clinical Oncology, 1998
- Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer.Journal of Clinical Oncology, 1997
- Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinomaCancer, 1997
- Chemotherapy with Methotrexate, Vinblastine, Epirubicin and Carboplatin (Carbo-MVE) in Transitional Cell Urothelial CancerEuropean Urology, 1997
- Carboplatin-based chemotherapy for bladder cancerCancer Treatment Reviews, 1993
- A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.Journal of Clinical Oncology, 1992
- A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.Journal of Clinical Oncology, 1990
- Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseCancer, 1989